[Federal Register Volume 89, Number 121 (Monday, June 24, 2024)]
[Notices]
[Pages 52483-52484]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13766]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed project 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer at (240) 276-0166.
    Comments are invited on: (a) whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Project: State Opioid Response (SOR)/Tribal Opioid Response (TOR) 
Program Instrument (OMB No. 0930-0384)--Revision

    SAMHSA is requesting approval to modify its existing SOR/TOR 
Program Instrument by (1) broadening language from `naloxone' to 
`naloxone and other opioid overdose reversal medications' due to the 
availability of new FDA-approved non-naloxone overdose reversal 
medications; (2) broadening language from `fentanyl test strips' to 
`drug checking technologies as directed by SAMHSA' due to the 
availability of new drug checking technology, including test strips for 
other emerging substances; (3) reducing the number of questions from 12 
to 10 by combining four questions with similar themes into two 
questions for clarity; (4) removing question 12 because it is comprised 
of more than one question with several different ideas, making it 
unsuited for this instrument; and (5) adding one question at the 
request of Office of National Drug Control Policy (ONDCP)to collect 
information on Congressionally mandated and programmatic activities and 
comply with reporting requirements. The program-level information is 
collected quarterly and entered and stored in SAMHSA's Performance 
Accountability and Reporting System, which is a real-time, performance 
management system that captures information on SAMHSA funded substance 
use and substance use disorder prevention, harm reduction, treatment, 
and recovery support services, and mental health services delivered in 
the United States. Continued approval of this information collection 
will allow SAMHSA to continue to meet Government Performance and 
Results Modernization Act (GPRA) of 2010 reporting requirements that 
quantify the effects and accomplishments of its discretionary grant 
programs.
    The SOR/TOR programs are authorized under the Consolidated 
Appropriations Act, 2023, Division H, Title II [Pub. L. 117-328], and 
section 1003 of the 21st Century Cures Act [Pub. L. 114-255] (42 U.S.C. 
290ee-3a), as amended. SOR/TOR programs aim to address the opioid 
crisis by increasing access to FDA-approved medications for the 
treatment of opioid use disorder (MOUD), and support the continuum of 
prevention, harm reduction, treatment, and recovery support services 
for opioid use disorder (OUD) and other concurrent substance use 
disorders. The SOR program also supports the continuum of care for 
stimulant misuse and use disorders, including for cocaine and 
methamphetamine.
    SAMHSA is proposing to revise the SOR/TOR Program Instrument data 
collection instrument (OMB No. 0930-0384), to collect information on 
Congressionally mandated and programmatic activities and comply with 
reporting requirements.
    SAMHSA developed the SOR/TOR Program Instrument to collect minimum 
data on naloxone purchase and distribution, but the SOR/TOR programs 
are unique in that they have prevention, education, and harm reduction 
requirements. SOR/TOR grantees are required to engage in the following 
prevention and education activities: (1) train peers, first responders, 
and other key community sectors on recognition of opioid overdose and 
appropriate use of the opioid overdose antidote naloxone; (2) develop 
evidence-based community prevention efforts such as strategic messaging 
on the consequences of opioid and stimulant misuse; (3) implement 
school-based prevention programs and outreach; and (4) purchase and 
distribute opioid overdose antidote reversal naloxone based on the

[[Page 52484]]

naloxone distribution and saturation plan, and train on its use. The 
revised tool will continue to allow SAMHSA to collect data on the 
required education and prevention activities, and better assess grantee 
performance on these activities. The revisions will continue to assist 
SAMHSA in providing comprehensive data on the full range of required 
activities to inform Congressionally mandated reports for the SOR 
program.
    In order to address these issues, SAMHSA is proposing to (1) 
broaden language from `naloxone' to `naloxone and other opioid overdose 
reversal medications' due to the availability of new FDA-approved non-
naloxone overdose reversal medications; (2) broaden language from 
`fentanyl test strips' to `drug checking technologies as directed by 
SAMHSA' due to the availability of new drug checking technology, 
including test strips for other emerging substances; (3) reduce the 
number of questions from 12 to 10 by combining four questions with 
similar themes into two questions for clarity; (4) remove question 12 
because it is comprised of more than one question with several 
different ideas, making it unsuited for this instrument; and (5) add 
one question at the request of ONDCP to collect information on 
Congressionally mandated and programmatic activities and comply with 
reporting requirements.
    A summary of the proposed changes includes:
     Broadening the language to include new medications and 
technologies that will provide SAMHSA data on the following:
    [cir] Purchase and distribution of naloxone and other opioid 
overdose reversal medications; and
    [cir] Purchase and distribution of drug checking technologies as 
directed by SAMHSA.
     The revised tool will provide SAMHSA with clarification on 
individuals recognizing an opioid overdose and appropriate use of 
naloxone and other opioid overdose reversal medication by collapsing 
two questions with a similar theme.
     The revised tool will provide SAMHSA with clarification on 
individuals educated on the consequences of opioid and/or stimulant 
misuse by collapsing two questions with a similar theme.
     One question will be added to provide data on the 
following:
    [cir] Types of entities that distribute naloxone and other opioid 
overdose reversal medications.
    The Center for Substance Abuse Treatment (CSAT) anticipates that 
the time required to collect and report the program-level information 
is approximately 18 minutes per response. Since the submission of the 
previous OMB package, there has been an increase in the number of 
respondents. The estimated burden associated with the program-level 
instrument includes an adjustment to reflect the current number of 
grantees.

                                            Table 1--Estimate of Annualized Hour Burden for SOR/TOR Grantees
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                             Number of     Responses per   Total  number   Burden  hours   Total  burden   Hourly  wage     Total  wage
         SAMHSA data collection             respondents     respondent     of  responses   per  response       hours            \1\            cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
Grantee-Level Instrument................             189               4             756             .30          226.80          $28.89       $6,552.25
                                         ---------------------------------------------------------------------------------------------------------------
    CSAT Total..........................             189               4             756             .30          226.80           28.89        6,552.25
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ The hourly wage estimate is $28.89 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21-1018 Substance Abuse, Behavioral
  Disorder, and Mental Health Counselors = $28.89/hr. as of May 2023 (https://www.bls.gov/oes/current/oes211018.htm. Accessed on April 17, 2024.)

    Send comments to the SAMHSA Reports Clearance Officer, 5600 Fishers 
Lane, Room 15E45, Rockville, Maryland 20857, OR email a copy to 
[email protected]. Written comments should be received by August 
23, 2024.

Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-13766 Filed 6-21-24; 8:45 am]
BILLING CODE 4162-20-P